Iberdomide-dexamethasone Alone or in Combination With Standard MM Treatment Regimens in Transplant Ineligible Newly Diagnosed Patients.
Clinical trial NCT05527340 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05527340
- Sponsor
- PETHEMA Foundation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-15
- Primary completion
- 2029-12-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.